Texas court decision on Dow Chemical breast implant liability could affect federal ruling.
This article was originally published in The Gray Sheet
Executive SummaryTEXAS COURT RULING ON DOW CHEMICAL BREAST IMPLANT LIABILITY could influence the Alabama District Court's ruling on whether to exempt the firm from product liability related to Dow Corning silicone breast implants. In the Texas case, a jury on Feb. 15 found both Dow Corning and Dow Chemical liable for damages. Judge Michael Schneider is reviewing the jury's finding and is expected to make a final ruling in the next two weeks.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.